Small biotech firm Ozyme is a France-based biotechnology research supplier with 11-50 employees and a strong focus on cell biology, immunology, and molecular biology products, indicating potential for high-quality scientific consumables and niche reagent sourcing.

Scientific talent focus With more than half of its staff holding doctoral or engineering qualifications, Ozyme presents opportunities for high-level collaboration, custom assay kits, and advanced technical support services that can be upsold to research projects.

Sustainability posture The emphasis on engagement and competence of its team suggests a culture receptive to reliable supplier partnerships, training programs, and sustained procurement contracts for core lab supplies.

Digital footprint Ozyme utilizes modern tech stack (Platform.sh, Google Tag Manager, reCAPTCHA, Webpack, Clarity) signaling openness to digital procurement, partner portals, and e-commerce enhancements for streamlined purchasing.

Growth opportunities Despite a modest revenue range and modest headcount, potential sales openings exist in expanding catalog coverage, accessing specialized reagents, and offering value-added services like scientific advisory, training, or joint marketing with researchers.